logbook_erin
TL3 Regular · Halifax, CA
Keeps a very thorough log and shares the template. Weight, waist, protein, steps, sleep, side-effect scores.
Joined 8 October 2024 · last posted 17h · groups: wiki-editors, newcomer-guides
154 posts, newest first. Showing up to 150.
-
Reporting a good result: why nobody bothers and why they should Replied, post #3 · Sourcing › Vendor reports · 27 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Pattern across lots: a single result is a data point. Three or four results from the same…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #52 · Clinical › Prescriber conversations · 26 Jul 2026 · 28 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Pooling trials with different estimands Replied, post #128 · Evidence › Meta-analyses · 25 Jul 2026 · 1 like Picking up post #125: that is the part I would want checked first. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #100 · Nutrition & Training › Protein & intake · 24 Jul 2026 · 0 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Follow-up: UK access routes, dated and sourced Replied, post #14 · Regional › UK & Ireland · 23 Jul 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Immortal time bias in a claims-database study — one year on Replied, post #38 · Evidence › Study critique · 22 Jul 2026 · 5 likes Picking up post #35: that is the part I would want checked first. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with…
-
A site rotation scheme that is easy enough to actually follow Replied, post #119 · Practice › Administration · 19 Jul 2026 · 6 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Seven-day rolling means and why weekly readings mislead Replied, post #58 · Outcomes › Progress reports · 19 Jul 2026 · 9 likes Coming back to post #56, because the follow-up matters more than the original answer. Seasonal patterns: some people report weight loss is slower in winter than summer.…
-
The headache that turns out to be dehydration — the long version Replied, post #69 · Nutrition & Training › Hydration & electrolytes · 18 Jul 2026 · 32 likes post #68 is right about the mechanism and I think understates the practical bit. Exercise and electrolyte losses: sweating during exercise increases sodium and…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #14 · Analytics › Impurities & related substances · 17 Jul 2026 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Programming during a large energy deficit Replied, post #41 · Nutrition & Training › Resistance training · 16 Jul 2026 · 31 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why the timeline is on the right and not the left — what changed since Replied, post #74 · Meta › Site feedback · 14 Jul 2026 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #65 · Evidence › Journal club · 13 Jul 2026 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #97 · Evidence › Journal club · 11 Jul 2026 · 0 likes post #96 is right about the mechanism and I think understates the practical bit. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #41 · Analytics › Home & field testing · 30 Jun 2026 · 0 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
How this community escalates rather than diagnoses — does this still hold? Replied, post #5 · Safety › Adverse events · 29 Jun 2026 · 9 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #28 · Analytics › Impurities & related substances · 27 Jun 2026 · 10 likes post #27 is right about the mechanism and I think understates the practical bit. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a…
-
A site rotation scheme that is easy enough to actually follow Replied, post #97 · Practice › Administration · 24 Jun 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #18 · Evidence › Meta-analyses · 22 Jun 2026 · 0 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #121 · Practice › Reconstitution · 21 Jun 2026 · 13 likes Coming back to post #119, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #50 · Start Here › How to Ask · 18 Jun 2026 · 25 likes On post #46 — agreed on the reasoning, with one qualification. Five questions in one post gets you one answer: the easiest one, usually not the one you needed most.…
-
Revisiting: What pooling buys you and what it destroys Replied, post #58 · Evidence › Meta-analyses · 17 Jun 2026 · 3 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Constipation management, with a dietitian's contribution Replied, post #79 · Practice › Side effects · 15 Jun 2026 · 29 likes On post #75 — agreed on the reasoning, with one qualification. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #21 · Compounds › Secretagogues & GH axis · 11 Jun 2026 · 4 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Injecting into an area that has become firm: why not to Replied, post #5 · Practice › Administration · 2 Jun 2026 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
What to include when your question involves a chromatogram — one year on Replied, post #22 · Start Here › How to Ask · 1 Jun 2026 · 27 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #42 · Wellbeing › Sleep · 24 May 2026 · 0 likes Coming back to post #40, because the follow-up matters more than the original answer. Sleep quality versus quantity: some people report changes to sleep duration;…
-
Currency conversion and the cost you did not see Replied, post #3 · Sourcing › Payments · 20 May 2026 · 25 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #68 · Compounds › Tirzepatide · 19 May 2026 · 1 like Picking up post #65: that is the part I would want checked first. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #10 · Analytics › COA interpretation · 29 Apr 2026 · 1 like Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #50 · Practice › Interactions · 28 Apr 2026 · 0 likes Coming back to post #48, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Preservatives: function, testing, and limits — one year on Replied, post #12 · Pharmacology › Formulation chemistry · 24 Apr 2026 · 24 likes post #11 answers the question as asked. The question underneath it is different. Container closure: the vial material, rubber closure, and sealing all affect…
-
What a certificate commits its issuer to — the long version Replied, post #2 · Analytics › COA interpretation · 19 Apr 2026 · 12 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
The most useful thing you learned here that was not the answer you came for Replied, post #35 · Lounge › Off topic · 16 Apr 2026 · 3 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #47 · Practice › Administration · 14 Apr 2026 · 7 likes I read post #45 twice before replying, because I had assumed the opposite. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #88 · Practice › Reconstitution · 5 Apr 2026 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #6 · Compounds › Oral incretins · 2 Apr 2026 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #78 · Pharmacology › Pharmacokinetics · 21 Mar 2026 · 0 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #32 · Practice › Administration · 17 Mar 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #70 · Research Methods › N-of-1 designs · 16 Mar 2026 · 3 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #51 · Lounge › Introductions · 13 Mar 2026 · 22 likes Coming back to post #49, because the follow-up matters more than the original answer. Following up: if you introduce yourself and someone asks a follow-up question, you…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #14 · Meta › Announcements · 9 Mar 2026 · 6 likes This follows post #11 rather than contradicting it. Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #20 · Compounds › Repair & healing peptides · 9 Mar 2026 · 30 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #59 · Practice › Interactions · 2 Mar 2026 · 28 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #31 · Practice › Administration · 26 Feb 2026 · 23 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Coming back to: Time to steady state after a dose increase Replied, post #6 · Pharmacology › Pharmacokinetics · 26 Feb 2026 · 19 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #115 · Practice › Dosing & titration · 21 Feb 2026 · 10 likes Coming back to post #113, because the follow-up matters more than the original answer. Steady state means the plasma concentration is stable from dose to dose. That…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #25 · Practice › Interactions · 18 Feb 2026 · 0 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #19 · Clinical › Comorbidities · 15 Feb 2026 · 28 likes Picking up post #16: that is the part I would want checked first. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #27 · Compounds › Semaglutide · 14 Feb 2026 · 1 like The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Revisiting: Absolute versus relative contraindications Replied, post #15 · Safety › Contraindications · 13 Feb 2026 · 33 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…
-
Trifluoroacetate content and its consequences Replied, post #113 · Analytics › Impurities & related substances · 9 Feb 2026 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #76 · Pharmacology › Pharmacokinetics · 5 Feb 2026 · 0 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Personal import allowances, compared — a second dataset Replied, post #62 · Access › International · 2 Feb 2026 · 1 like This follows post #59 rather than contradicting it. Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it…
-
Trifluoroacetate content and its consequences Replied, post #46 · Analytics › Impurities & related substances · 30 Jan 2026 · 11 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
-
Revisiting: Absolute versus relative contraindications Replied, post #14 · Safety › Contraindications · 26 Jan 2026 · 1 like Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
Guidelines revision: what changed and why — one year on Replied, post #62 · Meta › Announcements · 24 Jan 2026 · 1 like Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #9 · Outcomes › Body composition · 20 Jan 2026 · 0 likes post #8 is right about the mechanism and I think understates the practical bit. Maintenance phase: tracking body composition during maintenance (weight stable) is…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #61 · Pharmacology › Pharmacokinetics · 16 Jan 2026 · 31 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
A partial dose because the pen emptied mid-injection Replied, post #91 · Practice › Administration · 10 Jan 2026 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #36 · Compounds › Tirzepatide · 7 Jan 2026 · 1 like On post #32 — agreed on the reasoning, with one qualification. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #23 · Documentation › Wiki requests · 4 Jan 2026 · 10 likes Coming back to post #21, because the follow-up matters more than the original answer. Flag a page that has drifted: if you notice a maintained page has information that…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #81 · Compounds › Oral incretins · 1 Jan 2026 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #6 · marked as the solution · Practice › Side effects · 26 Dec 2025 · 19 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Early satiety becoming a problem rather than a benefit Replied, post #18 · Practice › Side effects · 22 Dec 2025 · 11 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Prescription requirements and telehealth models Replied, post #83 · Sourcing › Regulatory · 22 Dec 2025 · 0 likes On post #79 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #3 · Practice › Storage & stability · 21 Dec 2025 · 0 likes post #2 answers the question as asked. The question underneath it is different. Protecting from light: amber vials or opaque containers reduce light exposure. If you…
-
Coming back to: Pen dose counters: what a click does and does not guarantee Replied, post #2 · Devices › Pens & autoinjectors · 19 Dec 2025 · 26 likes Picking up the opening post: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #7 · Research Methods › N-of-1 designs · 1 Dec 2025 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #23 · Research Methods › N-of-1 designs · 29 Nov 2025 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #25 · Access › Pricing · 28 Nov 2025 · 5 likes On post #21 — agreed on the reasoning, with one qualification. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an…
-
Sleep quality changes during weight loss — what changed since Replied, post #64 · Wellbeing › Sleep · 15 Nov 2025 · 4 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
What pooling buys you and what it destroys Replied, post #66 · Evidence › Meta-analyses · 14 Nov 2025 · 0 likes This follows post #63 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Batch date after test date, and other internal inconsistencies Replied, post #16 · Analytics › COA interpretation · 10 Nov 2025 · 1 like What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Reading SURMOUNT-1 without the press release Replied, post #55 · Compounds › Tirzepatide · 4 Nov 2025 · 9 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #12 · Devices › Pens & autoinjectors · 2 Nov 2025 · 0 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
Search filters: what is missing Started this topic · Meta › Site feedback · 30 Oct 2025 · 0 likes Search filters: what is missing — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons.…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #40 · Analytics › Home & field testing · 27 Oct 2025 · 6 likes This follows post #37 rather than contradicting it. Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result.…
-
Sleep tracking data and its considerable limitations Replied, post #39 · Wellbeing › Sleep · 20 Oct 2025 · 18 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
New subcategory: rationale and scope Replied, post #27 · Meta › Announcements · 15 Oct 2025 · 2 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Reading an interaction checker output critically Replied, post #19 · Practice › Interactions · 10 Oct 2025 · 4 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Follow-up: Why appetite effects are mostly central Replied, post #59 · Pharmacology › Receptor biology · 6 Oct 2025 · 3 likes On post #55 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Reading SURMOUNT-1 without the press release Replied, post #24 · Compounds › Tirzepatide · 4 Oct 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #57 · Compounds › Other compounds · 28 Sep 2025 · 18 likes Coming back to post #55, because the follow-up matters more than the original answer. Why catalogue breadth is not evidence of anything: a supplier listing 500…
-
Second pass at: Programming during a large energy deficit Replied, post #9 · Nutrition & Training › Resistance training · 16 Sep 2025 · 1 like Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #102 · Compounds › Oral incretins · 15 Sep 2025 · 2 likes This follows post #99 rather than contradicting it. Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #42 · Compounds › Repair & healing peptides · 12 Sep 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #94 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
Reading SURMOUNT-1 without the press release Replied, post #4 · Compounds › Tirzepatide · 7 Sep 2025 · 20 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Hypertension improvement and when medication needs revisiting Replied, post #35 · Clinical › Comorbidities · 1 Sep 2025 · 18 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Started this topic · Compounds › Tirzepatide · 29 Aug 2025 · 0 likes Asking directly, because I could not find a straight answer: Tirzepatide and nausea: is the profile genuinely different or just differently reported? Comparing PIONEER…
-
What this community means by "a source", in practical terms Replied, post #90 · Start Here › Welcome · 29 Aug 2025 · 0 likes Coming back to post #88, because the follow-up matters more than the original answer. Welcome. The orientation materials are pinned at the top of this category and they…
-
When to stop reading forums, including this one Replied, post #19 · Wellbeing › Mental health · 27 Aug 2025 · 0 likes post #18 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
When a preprint is the best available evidence and we say so Replied, post #61 · Evidence › Preprints · 16 Aug 2025 · 10 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
A ten-fold dose error caught before injection — one year on Replied, post #129 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
How to research a compound with no human data without deceiving yourself Replied, post #100 · Compounds › Other compounds · 4 Aug 2025 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
A newcomer's list of things that confused me, and the fixes Replied, post #14 · Start Here › Welcome · 15 Jul 2025 · 5 likes On post #10 — agreed on the reasoning, with one qualification. On the reading order question specifically: start with the how-to-ask materials in this category, then…
-
Sodium, potassium and magnesium when intake drops Replied, post #60 · Nutrition & Training › Hydration & electrolytes · 15 Jul 2025 · 2 likes post #59 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #50 · Data & Tools › Calculators · 13 Jul 2025 · 6 likes post #49 answers the question as asked. The question underneath it is different. The calculators maintained on this site are open-source and verifiable. They are…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #149 · Practice › Reconstitution · 29 Jun 2025 · 32 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Why the timeline is on the right and not the left Replied, post #33 · Meta › Site feedback · 25 Jun 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Sequence verification for an obscure compound: how it is done Replied, post #68 · Compounds › Other compounds · 20 Jun 2025 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #31 · Compounds › Semaglutide · 17 Jun 2025 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #21 · Sourcing › Regulatory · 9 Jun 2025 · 33 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Counter-ion content and its effect on measured mass Replied, post #56 · Analytics › Mass spectrometry · 4 Jun 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Regression to the mean in progress reports Replied, post #15 · Research Methods › Statistics · 31 May 2025 · 6 likes On post #11 — agreed on the reasoning, with one qualification. Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #133 · Compounds › Semaglutide · 25 May 2025 · 20 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading a trial's population section before its results — does this still hold? Replied, post #138 · Evidence › Trials · 23 May 2025 · 31 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Half-life, steady state, and accumulation worked through Replied, post #11 · Pharmacology › Pharmacokinetics · 22 May 2025 · 7 likes post #10 answers the question as asked. The question underneath it is different. Accumulation at steady state: with a week-long half-life, steady-state concentration is…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #39 · Regional › UK & Ireland · 22 May 2025 · 19 likes This follows post #36 rather than contradicting it. Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #22 · Clinical › Bloodwork · 20 May 2025 · 0 likes Coming back to post #20, because the follow-up matters more than the original answer. A single value outside interval: usually uninformative on a single draw. What…
-
Travel coolers and how long they really hold — the long version Replied, post #5 · Devices › Cold chain · 19 May 2025 · 8 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
EU-wide position versus national implementation Replied, post #4 · Regional › European Union · 10 May 2025 · 0 likes Picking up post #3: that is the part I would want checked first. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict…
-
Follow-up: Documentation that appears only after payment Replied, post #60 · Sourcing › Red flags · 9 May 2025 · 19 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #131 · Evidence › Journal club · 23 Apr 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Telehealth prescribing models in the US Replied, post #88 · Regional › North America · 22 Apr 2025 · 22 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #18 · Evidence › Journal club · 18 Apr 2025 · 25 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Reading an MS report that only gives you a single number Replied, post #52 · Analytics › Mass spectrometry · 13 Apr 2025 · 11 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #62 · Compounds › Semaglutide · 3 Apr 2025 · 17 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #119 · Sourcing › Regulatory · 2 Apr 2025 · 0 likes Picking up post #116: that is the part I would want checked first. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #46 · Analytics › Mass spectrometry · 26 Mar 2025 · 2 likes This follows post #43 rather than contradicting it. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is…
-
UK access routes, dated and sourced — a second dataset Replied, post #54 · Regional › UK & Ireland · 23 Mar 2025 · 0 likes post #53 answers the question as asked. The question underneath it is different. Ireland: the Health Products Regulatory Authority implements EU framework.…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #115 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #75 · Evidence › Journal club · 11 Mar 2025 · 15 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Scheduled maintenance and what will be unavailable Replied, post #66 · Meta › Announcements · 8 Mar 2025 · 11 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #47 · Compounds › Secretagogues & GH axis · 28 Feb 2025 · 26 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #122 · Evidence › Journal club · 10 Feb 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #30 · Practice › Reconstitution · 7 Feb 2025 · 4 likes post #29 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
What changed in 2026, by region Replied, post #123 · Access › International · 5 Feb 2025 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
What we do not know about retatrutide, listed explicitly Replied, post #82 · Compounds › Retatrutide · 4 Feb 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Protein density versus volume when you cannot eat much Replied, post #48 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 0 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Canadian access and provincial variation Replied, post #19 · Regional › North America · 25 Jan 2025 · 0 likes Coming back to post #17, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
When to suspect the method rather than the sample Replied, post #66 · Analytics › Method validation · 15 Jan 2025 · 0 likes Coming back to post #64, because the follow-up matters more than the original answer. Limits of detection and quantitation: LOD is the lowest concentration that…
-
Recovery when intake is low: what to cut first Replied, post #64 · Nutrition & Training › Resistance training · 13 Jan 2025 · 18 likes This follows post #61 rather than contradicting it. Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets.…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #76 · Compounds › Semaglutide · 23 Dec 2024 · 15 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Body image changing more slowly than the body Replied, post #83 · Wellbeing › Mental health · 20 Dec 2024 · 10 likes I read post #81 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
The topic list is dense — is that deliberate? Replied, post #69 · Meta › Site feedback · 19 Dec 2024 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Body image changing more slowly than the body Replied, post #68 · Wellbeing › Mental health · 18 Dec 2024 · 4 likes post #67 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #156 · Analytics › COA interpretation · 18 Dec 2024 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #72 · Access › Insurance & coverage · 16 Dec 2024 · 4 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #70 · Compounds › Tirzepatide · 3 Dec 2024 · 18 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #40 · Practice › Side effects · 2 Dec 2024 · 0 likes Coming back to post #38, because the follow-up matters more than the original answer. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #18 · Clinical › Special populations · 20 Nov 2024 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
EMA product information as a primary source — does this still hold? Replied, post #83 · Regional › European Union · 17 Nov 2024 · 20 likes I read post #81 twice before replying, because I had assumed the opposite. Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes…
-
EMA product information as a primary source — does this still hold? Replied, post #68 · Regional › European Union · 16 Nov 2024 · 32 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #25 · Access › Insurance & coverage · 13 Nov 2024 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #22 · Compounds › Semaglutide · 12 Nov 2024 · 0 likes I read post #20 twice before replying, because I had assumed the opposite. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects.…
-
Why "any advice?" is the least effective ending for a post Replied, post #11 · Start Here › How to Ask · 5 Nov 2024 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #15 · Sourcing › Regulatory · 27 Oct 2024 · 15 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Why a preprint's supplementary material is often the best part Replied, post #39 · Evidence › Preprints · 26 Sep 2024 · 2 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…